Jeffrey J. Kirshner MD, FACP, FASCO
Medical Oncologist, Hematology Oncology Associates of Central New York (HOACNY), East Syracuse, New YorkDr. Jeffrey J. Kirshner is a medical oncologist at Hematology Oncology Associates of Central New York (HOACNY) in East Syracuse and serves as an investigator in the Alliance for Clinical Trials in Oncology. He is an author or co-author of over 75 peer-reviewed research publications. He has an active clinical practice as well, currently specializing in breast cancer.
He received his medical degree from the University of Pennsylvania School of Medicine and completed residency and fellowship training at the SUNY Upstate Medical Center.
Dr. Kirshner has a strong interest in patient care and is actively involved in clinical research. He is also an active volunteer in Alliance and ASCO. He currently serves as the chair of the Data Safety and Monitoring Board for Alliance and is a member of several committees: Breast Committee, Symptom Intervention Committee, and Community Oncology Committee. He is a member of the ASCO Practice Guidelines Implementation Network and serves as the community oncology representative on four expert panels and the Cancer Survivorship Guidelines Advisory Group.
Recent Contributions to PracticeUpdate:
- 2021 Top Story in Oncology: Abemaciclib Plus Endocrine Therapy for Early Breast Cancer
- ESMO 2021: Recommendations From Dr. Jeffrey Kirshner for Symptom Management and Palliative and Supportive Care
- Ten Practice Changes That I Will Make After Attending Virtual ASCO 2021
- ASCO 2021: Abstract Recommendations From Dr. Jeffrey Kirshner for Symptoms and Survivorship
- Management of Bone Pain Among Patients With Breast Cancer
- 2020 Top Stories in Oncology: Data From the ADAURA Trial
- Key Takeaways From ESMO: Cardiotoxicity in Cancer Patients
- Key Takeaways From ESMO: Impact of Immunotherapy on Quality of Life
- ESMO 2020: Recommendations From Dr. Jeffrey Kirshner for Supportive and Palliative Care
- ASCO: Five Practice Changers From the Plenary Session